D.R. Pharmacy, Inc.
Form 483 issued March 17, 2006 · Midland, Texas
- Inspection
- Mar 17, 2006
- Investigator
- Stephen D. Brown
- Observations
- 13
- Pages
- 6
- FEI number
- 3005623291
In short: On March 17, 2006, FDA issued a Form 483 with 13 observations to D.R. Pharmacy, Inc. in Midland, Texas (FEI 3005623291) after an inspection that ran Mar 17, 2006. The investigator was Stephen D. Brown. Most observations concern materials; the most-cited regulation is 21 CFR 211.80 (general requirements).
At a glance
Observations span 1 system, led by materials.
Most cited: 21 CFR 211.80 (1×)
What FDA observed
Preview: the opening words of each observation- 01
regard to compounded drug…
- 02
fter 2103, the firm did not conduct testing for potency of…
- 03
n regard to environmental monitoring in the Laminar Flow Hoods (Class 100 area) installed in 002…
- 04
is routinely used as a preservative in various rnrnnll'\1 not conducted preservative effectiveness ......,itii'V'I IL...nrno examples…
This inspection in context
Stephen D. Brown
42 documents · 2006–2021
Cites 211.113 (control of microbiological contamination) more than any other section. Most of their documents are for sites in Texas.
The firmD.R. Pharmacy, Inc. history
All 2 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 211.80
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at D.R. Pharmacy, Inc.?
FDA listed 13 observations on this Form 483, mostly about materials. The most-cited regulation is 21 CFR 211.80 (general requirements). The opening words of each observation are shown on this page.
Who inspected D.R. Pharmacy, Inc.?
Stephen D. Brown is named on this Form 483, for the inspection of Mar 17, 2006. Each investigator has a profile showing what they cite most.
When was D.R. Pharmacy, Inc. inspected by FDA?
The inspection ran Mar 17, 2006, and the Form 483 is dated March 17, 2006.
How do I get the full Form 483 for D.R. Pharmacy, Inc.?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.